Page 12

The Power of

Precision Cancer Treatment Cancer Treatment Centers of America® (CTCA) now offers expanded genomic tumor assessment, a form of precision medicine that may identify cancer treatment options many patients haven’t previously considered. This innovation reveals the DNA alterations that are driving the growth of a cancer, which better enables us to provide cancer treatment therapies that target changes in the tumor’s genomic profile. At CTCA®, we believe that every family, every patient, and every tumor deserves a personalized treatment plan. Genomic tumor assessment is helping us better understand individual tumors, right down to their unique genetic composition, taking personalized treatment to a new level of care. If you or a loved one has complex or advanced-stage cancer, call (888) 568-1571 or visit

© 2013 Rising Tide

Hospitals in Atlanta, Chicago, Philadelphia, Phoenix, and Tulsa

No case is typical. You should not expect to experience these results.

2013 December Oklahoma Magazine  

Great Companies To Work For Featuring QuiBids’ Matt Beckham, Bama’s Paula Marshall and 54 Oklahoma Companies